Consensus Laboratorios Farmaceuticos Rovi, S.A.

Equities

Market Closed - BME Other stock markets 11:35:22 2024-05-15 am EDT			After market 01:21:20 pm
85.75 ^EUR	+1.60%		85.75	0.00%

May. 08	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment	MT

525cb9e78e28.i4-x5utCoo_gb-qqGs1H1EbEIkaNfXv32zmt_ukaVy4.xuz0i4Z16tmOGaj4eaQQnz7zSyq_Ljy_glDLpKBCAWPk3uGkjSfQ_pc-ow~4a5d65996432bd642d7619551f570287

22-02-23

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

84.4 EUR

Average target price

89.44 EUR

Spread / Average Target

+5.97%

High Price Target

100.5 EUR

Spread / Highest target

+19.08%

Low Price Target

68 EUR

Spread / Lowest Target

-19.43%

Trading Rating

Investor Rating

ESG Refinitiv

B+